Date(s) - 06 Jun 2019
4:00 pm - 5:00 pm
Improvements in data quality allow information integration on the scale impossible in just the recent past. Think of being able to effortlessly link compound data with lab assay information, then with animal disease models and information from human clinical trials.
Research that today requires a lot of specialized expertise and a lot of time for traditional paper-based review could become a trivial task. The resulting knowledge graphs would greatly reduce the human effort needed to guide the scientific discovery and may provide for a multitude of options for use of artificial intelligence to supplement the human mind. Enter the AssayNet, a pioneering project of the Medicines Discovery Catapult, that aims to to accomplish just that.
Dr. John Overington, the CIO of the Medicines Discovery Catapult will describe the project and its very far reaching implications.
After registering, you will receive a confirmation email containing information about joining the webinar.
Image credit: Joshua Sortino, Unsplash